Abstract
The combination of chemotherapy and phototherapy has become a promising cancer treatment strategy. In this study, a pH/NIR dual-responsive hollow mesoporous silica nanoparticles (HMSNs) based nanocarrier for co-delivering doxorubicin hydrochloride (DOX) and indocyanine green (ICG) was developed. DOX was loaded for chemotherapy and ICG for photothermal therapy (PTT) and photodynamic therapy (PDT). This system targets the asialoglycoprotein receptor (ASGPR) in over-expressing human hepatocellular liver carcinoma cells (HepG2) by linking HMSNs and lactobionic acid (LA)-modified dialdehyde chitosan (DACS) via Schiff base bonds. It is demonstrated that HMSNs-DACS-LA have been successfully prepared through various physical characterizations. Drug release tests revealed that it had the characteristics of properties of pH/NIR dual-responsive. In vitro cellular uptake and cytotoxicity assay showed that ID@HMSNs-DACS-LA could target HepG2 cells and reduced the activity of tumor cells. Therefore, co-delivery of ICG and DOX via HMSNs-DACS-LA nanocarriers may provide a feasible strategy for tumor-targeted combined chemotherapy and phototherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
